BIRAD Research & Development Company

BIRAD Research & Development Company is the commercial gateway for Bar-Ilan University, tasked with transforming academic breakthroughs into market-ready solutions. As a technology transfer office, it manages a robust portfolio of intellectual property across diverse fields, including life sciences, nanotechnology, and medical engineering. The company facilitates commercialization through licensing agreements, strategic industrial partnerships, and the creation of venture-backed spin-off companies. Notable areas of focus include innovative drug delivery systems like Nano-Ghost, ophthalmological breakthroughs such as Nano-Drops, and advanced therapies for neurodegenerative diseases. BIRAD provides comprehensive support to researchers and industrial partners, offering services in patent management, sponsored research, and scientific consulting. Through its collaborations with firms like the Arieli Group, BIRAD continues to accelerate the development of pharmaceutical and healthcare technologies to address global unmet medical needs.